Supravital dithizone staining in the isolation of human and rat pancreatic islets.

Paper

Supravital dithizone staining in the isolation of human and rat pancreatic islets.

Published Feb 1, 1989 · W. A. Hansen, Michael R. Christie, Robin Kahn

Diabetes research

UNKNOWN SJR score

42

Citations

1

Influential Citations

Semantic Scholar

Abstract

Dithizone, a zinc chelating agent, is known to selectively stain the islets of Langerhans in the pancreas. In the present study, we have used this stain to aid the identification of islets in material obtained by collagenase digestion of human pancreas. Islets were shown to rapidly and reversibly stain red on incubation with dithizone solution. Tissue selected on the basis of dithizone staining was shown to contain insulin-positive cells and to accumulate insulin in the medium during a subsequent period in tissue culture. Experiments with rat islets indicated that the dithizone treatment had no effect on insulin release in tissue culture, on acute responses to stimulatory glucose concentrations or on the insulin content of cells. These results suggest that dithizone staining can assist in the identification of islets from the human pancreas and may prove to be a useful tool in developing techniques for the large scale isolation of functionally intact human islets.

In Vitro Study

Study Snapshot

Dithizone staining can aid in the identification of human pancreatic islets, potentially aiding in large-scale isolation of functionally intact human islets.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Supravital dithizone staining in the isolation of human and rat pancreatic islets.

Sign up to use Study Snapshot

References

Citations

PEGDA microencapsulated allogeneic islets reverse canine diabetes without immunosuppression

PEGDA microencapsulated canine islets can effectively reverse diabetes in dogs without immunosuppression, leading to insulin-independence or significantly lowering insulin requirements.

AKAP79/150 coordinates leptin-induced PKA signaling to regulate KATP channel trafficking in pancreatic β-cells

AKAP79/150 plays a novel role in coordinating leptin and PKA signaling to regulate KATP channel trafficking in pancreatic -cells, ultimately regulating insulin secretion.

AKAP79/150 coordinates leptin-induced PKA activation to regulate KATP channel trafficking in pancreatic β-cells

AKAP79/150 plays a novel role in coordinating leptin and PKA signaling to regulate pancreatic -cell function.

Patient-derived pancreas-on-a-chip to model cystic fibrosis-related disorders

Defective CFTR function in pancreatic ductal epithelial cells significantly reduces insulin secretion in pancreatic islets, as demonstrated in a pancreas-on-a-chip model.

The Flaws and Future of Islet Volume Measurements

The islet equivalency (IEQ) method has been the standard for islet volume measurements, but its accuracy has been questioned and alternatives have been proposed.

Differentiation of stem cells into insulin‐producing cells under the influence of nanostructural polyoxometalates

Both nanostructured polyoxometalates (POMs) with W have significant biological activity, acting as active stimuli for stem cell differentiation into insulin-producing cells without toxic effects.

Experimental diabetes induced by alloxan and streptozotocin: The current state of the art.

Current animal models of diabetes induced by alloxan and streptozotocin need improvement to improve prevention, diagnosis, and treatment.

Evolution of Islet Transplantation for the Last 30 Years

Islet transplantation has progressed since the 1960s, but remains experimental due to barriers in human pancreas availability, immunosuppression, and islet isolation.